|
|
Volumn 29, Issue 10, 2011, Pages 860-863
|
|
Attacks on asthma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2' AMINO, 2' DEOXYADENOSINE PHOSPHOROTHIOATE;
ANTIASTHMATIC AGENT;
ANTISENSE OLIGONUCLEOTIDE;
ASM 8;
BENRALIZUMAB;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE PLUS FORMOTEROL;
CINQUIL;
CORTICOSTEROID;
CYT 003 QBG10;
ENOKIZUMAB;
FIBOFLAPON;
FLUTICASONE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR;
GSK 2190915;
HUMAN MONOCLONAL ANTIBODY;
INTERLEUKIN 13;
INTERLEUKIN 3 RECEPTOR;
INTERLEUKIN 4;
INTERLEUKIN 5 RECEPTOR;
INTERLEUKIN 9;
LEBRIKIZUMAB;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MEPOLIZUMAB;
MONTELUKAST;
MUSCARINIC RECEPTOR BLOCKING AGENT;
PHOSPHOROTHIOIC ACID DERIVATIVE;
PITRAKINRA;
RELOVAIR;
RESLIZUMAB;
TOLL LIKE RECEPTOR 9;
TRALOKINUMAB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VILANTEROL;
ADD ON THERAPY;
ARTICLE;
ASTHMA;
BIOTECHNOLOGY;
BRONCHODILATATION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG TARGETING;
HEALTH CARE COST;
HUMAN;
IMMUNOTHERAPY;
INFLAMMATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
VIRUS LIKE AGENT;
WHEEZING;
ADMINISTRATION, INHALATION;
ANTI-ASTHMATIC AGENTS;
ANTIBODIES, MONOCLONAL;
ASTHMA;
CLINICAL TRIALS, PHASE II AS TOPIC;
DRUG INDUSTRY;
HUMANS;
MOLECULAR TARGETED THERAPY;
OLIGONUCLEOTIDES;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
|
|
EID: 80054733269
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.1994 Document Type: Article |
|
Times cited : (10)
|
|
References (7)
|
